Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Recruiting now · Not applicable
Conditions studied: HIV Infections, Sexually Transmitted Diseases
In brief
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
Key facts
- Study ID
- NCT04855773
- Run by
- Public Health Foundation Enterprises, Inc.
- People needed
- 300
- Starts
- 2021-07-21
- Expected to finish
- 2023-08-01
- Last updated by the study team
- 2022-09-28
Who can join
Age: 15 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)
- Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months
- Age 15 years or older
- Willing and able to provide written informed consent
- Owns an iOS or Android mobile phone and able to access the internet and send and receive text messages
- Able to understand, read, and speak English or Spanish
- Newly initiated PrEP or currently on PrEP and at risk for PrEP discontinuation based on at least one of the following:
- Initiated PrEP within the past 6 months, or
- Has any of the following risk factors for PrEP discontinuation: missed clinic visits; age < 30; African-American or Latino; transgender gender identity; or self-reported illicit substance use
You may not qualify if…
- Currently enrolled in another PrEP intervention study
- Unable to complete 12 month study participation
- Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Where it is running
- San Francisco AIDS Foundation — San Francisco, California, United States (enrolling)
- Whitman-Walker Health — Washington D.C., District of Columbia, United States (enrolling)
- University of Miami — Miami, Florida, United States (enrolling)
- Bridge HIV, San Francisco Department of Public Health — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.